Clinical Trial Update: Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)

View source ↗

Summary

Sanofi-sponsored real-world study evaluating treatment outcomes in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy

Snippet

Sponsor: Sanofi | Conditions: Polyneuropathy, Inflammatory Demyelinating, Chronic | Status: RECRUITING